Cardiac Flashcards

1
Q

Prehypertension measurements

A

120-139/80-90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is primary hypertension?

A
  • Sustained elevation of 140/90 or higher
  • Results from environmental or genetic factors
  • Affects 90-95% of individuals with hypertension
  • Also called essential or idiopathic hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Modifiable Risk Factors for Hypertension

A
  1. Smoking
  2. DM
  3. HLD
  4. Obesity
  5. Physical inactivity
  6. Unhealthy diet
  7. Excessive sodium intake
  8. Excessive alcohol intake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Non-modifiable Risk Factors for Hypertension

A
  1. Chronic kidney disease
  2. Family history
  3. Increased age
  4. Low socioeconomic status
  5. Low educational status
  6. Male sex
  7. OSA
  8. Psychosocial stress
  9. Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HTN increases the risk of developing…

A
  • heart disease
  • kidney disease
  • hardening of the arteries (atherosclerosis or arteriosclerosis)
  • eye damage (retinopathy)
  • stroke (ischemic and hemorrhagic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is end-organ damage?

A

A complication of hypertension
- called this because damage to these organs is the end result of chronic (long duration) high blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What to ask for evaluation of hypertension?

A
  • duration and levels of elevated BP
  • past treatments (both successes and failures)
  • associated symptoms that suggest secondary HTN
  • symptoms of stress
  • weight control
  • physical activity/sedentary lifestyle
  • tobacco use
  • dietary intake
  • medications
  • psychosocial and environmental factors that may impact BP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Associated symptoms that suggest secondary HTN

A
  • palpitations
  • sweating
  • dizziness
  • abdominal pain
  • back pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Medications to ask about when evaluating HTN

A
  • illicit drug use
  • oral contraceptives
  • NSAIDs (can increase BP)
  • decongestants
  • steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnosis of HTN

A
  • obtain 2 or more BP with patient in chair after 5 minutes of rest (no caffeine or smoking 30 minutes prior)
  • measure height, weight, waist circumference with waist/hip ratio and BMI
  • excess body fat: waist >34 in. for women and >39 in. for men there is an increased risk for CVD
  • perform funduscopic exam
  • perform complete heart exam (bruits, thrill, edema)
  • perform complete neuro exam
  • ECG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lab Tests to do for HTN patients

A
  • UA (may reveal proteinuria)
  • electrolytes
  • calcium
  • creatinine
  • fasting lipid profile
    ** Goal is to identify target organ damage, any underlying cause and/or additional risk factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hypertension Prevention

A
  • maintenance of healthy weight and BMI
  • smoking cessation
  • regular aerobic exercise
  • alcohol in moderation (<1 oz per day)
  • stress management
  • adherence to medication regimen
  • assess for and treat OSA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is it important to assess medication adherence for HTN treatment?

A

It is important to identify obstacles to effective treatment
- cost?
- hard to get?
- sexual dysfunction/side effects?
**Ask them to bring their medications in to the office

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment strategy for HTN Stage 1

A

if no history of CVD, and risk score is <10%, initiate lifestyle changes first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment strategy for HTN Stage 2

A

lifestyle changes AND medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Things to consider when starting BP medications…

A
  1. ACE inhibitors can increase potassium
  2. Avoid beta blockers in individuals with DM and reactive airway disease
  3. Avoid ACE inhibitors in childbearing women: CategoryX
  4. Start low, go slow
  5. Maximize one medicine then consider adding a new medication (start at lowest dose, then increase)
  6. If cannot control BP… REFER!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How often to reassess HTN patients?

A

Reassess monthly until patient reaches goal, then every 3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Peripheral Artery Disease (PAD)

A
  • atherosclerotic disease of arteries that perfuse the limbs, especially lower extremities
  • especially prevalent in patients with DM
  • often asymptomatic
  • could have intermittent claudication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is intermittent claudication?

A

Obstruction of arterial blood flow in the iliofemoral vessels resulting in pain with ambulation
- fatigue, discomfort and/or pain that occurs in specific leg muscle groups during walking because of exercised induced ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is critical limb ischemia?

A
  • can occur with PAD
  • it is pain that occurs at rest or impending loss of limb caused by severe restriction in blood flow.
  • ischemia exceeds 2 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is acute limb ischemia?

A
  • occurs with PAD
  • has rapid onset (hours)
  • urgent recognition with prompt revascularization is required to prevent loss of limb
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is OLDCARTS?

A

Used for PAD assessment
O - onset
L - location
D - duration
C - characteristics
A - alleviating/aggravating factors
R - radiation/relieving factors
T - timing
S - severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Raynaud Phenomenon

A
  • PAD
  • episodic vasospasm (ischemia) in arteries and arterioles of the fingers, less commonly in the toes
  • is secondary to other systemic diseases or conditions (exposure to cold, pulm htn, smoking, scleroderma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Raynaud Disease

A
  • PAD
  • is a primarily vasospastic disorder of unknown origin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Thromboangniitis obliterans (Buerger disease)

A
  • causes pain, tenderness, and hair loss in the affected area
  • symptoms are caused by slow sluggish blood flow
  • can often lead to gangrenous lesion
  • occurs mainly in young men who smoke
  • inflammatory disease of peripheral arteries resulting in nonatherosclerotic lesions (spasm, thrombi, T-cell activation)
  • digital, tibial, plantar, ulnar, and palmar arteries
  • obliterates the small and medium-sized arteries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

PAD Clinical Presentations

A
  • often have no complaints
  • intermittent claudication or atypical leg pain (atypical pain usually due to co-morbidities)
  • patients may present initially with a threatened limb (critical limb ischemia)
  • may have non healing wound/ulcer
  • skin discoloration and gangrene
  • lack of hair growth on lower limbs
  • thickened toenails
  • diminished or absent pulses
  • bruits in abdominal, femoral, or popliteal area
  • pale, cool extremities
  • muscular atrophy
  • prolonged capillary refill
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

PAD Diagnostic Tests

A
  • Ankle Brachial Index (ABI)
  • Doppler ultrasound
  • CBC
  • BMP
  • C reactive protein (CRP)
  • erythrocyte sedimentation rate (ESR)
  • X ray (especially if there are wounds [osteomyelitis])
  • contrast angiography
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Ankle-Brachial Index (ABI)

A
  • used for PAD diagnostics
  • a comparison of upper extremity BPs to lower extremity BPs
  • looking at vascular health
  • <0.9 diagnostic for occlusive arterial disease
  • > 1.3 suggests presence of calcified vessels and need for additional testing such as exercise ABI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

PAD Treatment

A
  • lifestyle modifications
  • stop smoking (smokers have a particularly strong risk of PAD)
  • control DM
  • control BP
  • be physically active (including a supervised exercise program)
  • eat a low saturated-fat, low-cholesterol diet
  • drug treatment includes medicines to help improve walking distance (cilostazol, pentoxyfyline)
  • antiplatelet agents
  • cholesterol lowering agents (statins)
  • angioplasty or surgery may be necessary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Consultation/Referral for patient with PAD

A
  • refer to vascular surgeon for persistent symptoms or moderate or severe ischemia
  • refer if exercise and meds have not helped after 3-6 months (75% of patients will improve on this regimen)
  • refer all non healing ulcers
  • critical limb ischemia, gangrene, ulceration or pain at rest are present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Complications of PAD

A
  • amputation
  • intractable pain
  • immobility
  • ischemia leads to necrosis leads to gangrene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Orthostatic Hypotension

A
  • decrease in systolic (by 20 mm Hg or more) and diastolic (by 10 mm Hg or more) blood pressure upon standing
  • lack of normal blood pressure compensation in response to gravitational changes on the circulation
  • 2 types (acute and chronic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Acute Orthostatic Hypotension

A
  • common in diabetics, blood loss, and elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Chronic Orthostatic Hypotension

A
  • primarily seen in older men
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Atrial Fibrillation

A
  • supraventricular tachyarrhythmia characterized by rapid uncontrolled uncoordinated atrial activation with deterioration of atrial mechanical function
  • can reduce cardiac output by as much as 30%; blood can pool in the atrium, causing a clot in the left atrial appendage
  • increases the risk of ischemic stroke fivefold
  • up to 25% of all strokes in older adult population occur secondary to Afib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Types of Atrial Fibrillation

A
  1. paroxysmal
  2. persistent
  3. longstanding persistent
  4. permanent
  5. nonvalvular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Paroxysmal A fib

A

AF ends spontaneously or after intervention within 7 days of onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Persistent A fib

A

AF continues for more than 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Longstanding Persistent A fib

A

continuous A fib for more than 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Permanent A fib

A

AF when no longer attempting to restore or maintain sinus rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Nonvalvular A fib

A

AF in the absence of rheumatic mitral stenosis, heart valve replacement, or mitral valve repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

A-Fib Risk Factors

A
  • increasing age
  • hypertension
  • DM
  • vascular disease
  • smoking
  • inactivity
  • hyperthyroidism
  • heart failure or left ventricular hypertrophy (LVH)
  • obesity
  • obstructive sleep apnea
  • genetic variants (fam hx, euro descent)
  • cardiothoracic surgery
  • valvular heart disease (VHD)
  • increased pulse pressure
  • LVH on EKG
  • enlarged left atrium (LA), increased thickness of LV wall, decreased LV fractional shortening on echocardiogram
  • increased CRP or BNP
    ** Reversible causes include pulmonary embolism, caffeine intake, alcohol, fevers, and infectious origin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Assessment Findings for Afib

A
  • irregular or rapid heart tones
  • irregular peripheral pulses
  • subjective symptoms include unusual heartbeats (racing, fluttering, palpitations), shortness of breath, lightheadedness
  • hypotension (due to poor blood perfusion)
  • elevated jugular venous pressure (blood is pooling, so there is backflow)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Diagnostic Studies for Afib

A
  • 12 lead EKG
  • Holter monitor
  • Pulse oximeter
  • TSH, CMP, CBC
  • transthoracic echocardiogram
  • chest xray
  • PT/INR
  • stress test
  • transesophageal echocardiogram
45
Q

Who manages initial care of Afib patients?

A

Cardiologist

46
Q

Afib Treatment

A
  • Anticoagulation
  • Rate control meds
  • Rhythm control meds
  • digoxin
47
Q

Anticoagulation for Afib

A
  • new/novel oral anticoagulants (NOACs) are recommended over warfarin where eligible, except in patients with moderate to severe mitral stenosis or mechanical heart valve
  • initiation based on risk for thromboembolism independent of Afib type, on stroke/bleed risks, basis of Afib (valvular or nonvalvular), renal function, and patient preferences
  • warfarin is the only approved anticoagulant for valvular Afib
  • NOAC (dabigatran, rivaroxaban, apixaban)
48
Q

Rate control meds for Afib

A
  • Beta blockers (-olol’s)
  • Calcium channel blockers
49
Q

Types of CCBs used for Afib

A
  • verapamil
  • diltiazem
50
Q

Rhythm control meds for Afib

A
  • amiodarone
  • dronedarone
51
Q

Complications of Afib

A
  • hemorrhagic stroke
  • ischemic stroke
  • bleeding secondary to anticoagulation
  • bradycardia secondary to rate control medications
  • pulmonary fibrosis, hypothyroidism with long-term use of amiodarone
52
Q

Chest Pain

A
  • discomfort or a sensory pain response to noxious stimuli associated with actual or potential tissue damage involving the chest wall, thoracic organs, and adjacent structures
  • location may be anywhere along the front and back of the body between neck and upper abdomen
53
Q

Origins of chest pain

A
  • chest wall
  • lungs
  • cardiac
  • GI
  • psychogenic/psychosomatic
54
Q

Chest wall origin of chest pain

A
  • bones
  • muscles
  • nerves
  • cartilagenous tissue
  • skin
55
Q

Lung origin of chest pain

A
  • lung
  • pleura
  • diaphragm
  • infection
  • neoplasm
55
Q

Cardiac origin of chest pain

A
  • heart
  • pericardium
  • epicardium
  • mediastinum
56
Q

GI origin of chest pain

A
  • stomach
  • esophagus
  • gallbladder
  • duodenum
  • hiatal hernia
57
Q

Psychogenic/Psychosomatic origin of chest pain

A
  • anxiety
  • depression
  • panic attack
58
Q

Chest Pain Treatment

A
  • plan/management
  • pain relief
  • treatment of underlying cause
  • referral for proper follow up (cardio, GI, psych)
  • educate patient and family about cause
59
Q

Heart Failure

A
  • general term used to describe several types of cardiac dysfunction that result in inadequate perfusion of tissues with blood-borne nutrients
60
Q

Types of Heart Failure

A
  1. Congestive HF
  2. Diastolic HF
  3. Right sided HF
  4. High-output failure
61
Q

Congestive HF

A
  • systolic heart failure
  • inability of the heart to generate adequate cardiac output to perfuse tissues
62
Q

Diastolic HF

A
  • pulmonary congestion despite normal stroke volume and cardiac output
63
Q

Right HF

A
  • commonly caused by diffuse hypoxic pulmonary disease
  • can result from an increase in left ventricular filling pressure that is reflected back into the pulmonary circulation
64
Q

High-output Failure

A
  • inability of the heart to supply the body with blood-borne nutrients, despite adequate blood volume and normal or elevated myocardial contractility
65
Q

Left-sided HF symptoms

A

F - fatigue
O - orthopnea
R - rales/restless
C - cyanosis/confusion
E - extreme weakness
D - dyspnea

66
Q

Right-sided HF symptoms

A

B - bloating
A - anorexia
C - cyanosis/cool legs
O - oliguria
N - nausea
E - edema
D - distended neck veins

67
Q

Disorders caused by HF

A
  • pneumonia
  • COPD
  • bronchitis
  • cirrhosis
  • venous insufficiency
  • dependent edema
  • pulmonary embolism
68
Q

Diagnostic Studies for HF

A
  • BNP
  • NT-proBNP
    ** Both are important and are not interchangeable
69
Q

When to hospitalize patients with HF

A
  • pulmonary edema
  • cardiogenic shock
  • MI
  • O2 saturation > 90%
  • anasarca
  • pneumonia
70
Q

HF Treatment

A
  • goal of ejection fraction > 40%
  • First line therapy is for all patients regardless of severity is both an ACE inhibitor and a Beta Blocker (start low…go slow)
  • diuretics to manage fluid retention
71
Q

Loop Diuretics

A
  • used for HF
  • lasix
  • torsemide
  • bumetanide
72
Q

Aldosterone receptor antagonist

A
  • used for HF
  • spironolactone
  • eplerenone
73
Q

Heart Murmur

A

-the sound detected during turbulent blood flow through the heart or the great vessels due to one of the following
- blood forced through narrow passages (valvular stenosis)
- regurgitation through incompetent or abnormal valves (mitral valve regurgitation)
- increased blood flow across normal structures (anemia)
- shunting of blood from an area of high pressure to an area of lower pressure (ventricular septal defect)

74
Q

Risk Factors for Heart Murmur

A
  • age (common in children, older adults)
  • fever
  • anemia
  • pregnancy
  • thyrotoxicosis
  • HTN
  • rigid carotid arteries
  • MI
  • atrial tumor or thrombus (usually causes “tumor flop”)
  • congenital heart disease
  • valvular disease
  • bacterial, viral, or fungal infection of heart
75
Q

Grade 1 Heart Murmur

A

barely audible with intense concentration

76
Q

Grade 2 Heart Murmur

A

faint, soft, audible immediately

77
Q

Grade 3 Heart Murmur

A

moderately loud, no thrill palpable

78
Q

Grade 4 Heart Murmur

A

loud with palpable thrill

79
Q

Grade 5 Heart Murmur

A

very loud, audible with part of stethoscope off the chest; thrill palpable

80
Q

Grade 6 Heart Murmur

A

audible without a stethoscope on chest wall; thrill palpable

81
Q

Heart Murmur Diagnostic Testing

A
  • cardiac auscultation
  • electrocardiogram
  • chest xray
  • doppler echocardiography (transthoracic or thransesophageal)
  • stress echocardiography
  • angiography
  • cardiac catheterization
  • cardiac CT (or MRI)
82
Q

Physiologic Maneuvers useful in Diagnosing Heart Murmurs

A
  • respiration
  • abrupt standing and squatting
  • valsalva
  • hand grip
  • post extra systolic potentiation
83
Q

Heart Murmur: Respiration maneuver

A

systemic and pulmonary venous return change reciprocally with inspiration and expiration; alter certain heart sounds and murmurs

84
Q

Heart Murmur: abrupt standing and squatting maneuver

A

systemic venous return and arterial pressure change reciprocally; alters certain heart sounds and murmurs

85
Q

Heart Murmur: Valsalva maneuver

A

induces decrease in intensity of murmur of aortic stenosis and increases intensity of systolic ejection murmur of hypertrophic cardiomyopathy

86
Q

Heart Murmur: hand grip maneuver

A

increase in systemic vascular resistance: tends to decrease intensity of murmur of aortic stenosis and increase intensity of murmur of mitral regurgitation

87
Q

Heart Murmur: post extra systolic potentiation

A

clues to valvular heart disease

88
Q

Transient Ischemic Attack (TIA)

A

a transient episode of neurologic dysfunction due to the focal brain, spinal cord, or retinal ischemia, without acute infarction

89
Q

Three subtypes of TIA

A
  1. Cardioembolic
  2. Atherothrombotic
  3. Lacunar
90
Q

TIA Risk Factors

A
  • HTN
  • advanced age
  • prior TIA
  • smoking/tobacco use
  • DM
  • HLD
  • physical inactivity
  • cardiac disease
  • chronic kidney disease
  • afib
  • family history of TIA or stroke
  • oral contraceptive use
  • sickle cell disease
  • sleep apnea
  • carotid artery stenosis
  • hypercoagulable state
  • obesity
91
Q

TIA Assessment Findings

A
  • aphasia
  • visual field defects
  • confusion
  • amnesia
  • diplopia
  • dysphagia
  • dysarthria
  • unilateral weakness
  • symptoms of typically last < 60 minutes
  • transient global amnesia
92
Q

Diagnostic Studies for TIA

A
  • Brain imaging with CT and/or MRI of head: rule out hemorrhage or stroke
  • carotid studies (U/S and/or angiography); 70% blockage may cause symptoms
  • neurovascular studies such as CT angiography, MR angiography and/or ultrasound: may demonstrate atherosclerosis
  • 12 lead EKG, 24-hr Holter monitor, echocardiogram if underlying cardiac problem suspected
  • EEG if seizure is suspected
  • laboratory studies to rule out medical causes: CBC, PT/PTT, ESR, glucose, lipid profile, serum electrolytes, creatinine
93
Q

TIA Prevention

A
  • control BP
  • weight loss for vascular risk reduction
  • aerobic activity 3-4 times weekly
  • smoking cessation
  • limit alcohol consumption
  • antiplatelet therapy
  • statin therapy
  • sleep study (due to OSA correlation)
94
Q

TIA Treatment

A
  • use of antiplatelet agents rather than oral anticoagulants is recommended
  • recommended for 50-99% stenosis of a major intracranial artery (ASA, BP <140 mm HG, high intensity statin therapy)
  • apixaban, dabigatran
95
Q

Angina

A

syndrome characterized by short episodes of deep, poorly localized chest pain or arm discomfort associated with physical exertion or emotional stress and relieved with rest

96
Q

Acute Coronary Syndrome

A

any constellation of clinical symptoms suggestive of unstable angina or acute myocardial infarction

97
Q

Examples of Acute Coronary Syndromes

A
  • transient ischemia
  • unstable angina
  • sustained ischemia
  • MI
  • myocardial inflammation and necrosis
98
Q

Stable Angina

A
  • episodic
  • crescendo - decrescendo pattern
  • occurs on exertion and relieved by rest
  • last 2-5 minutes
99
Q

Unstable Angina

A
  • severe and new onset
  • crescendo pattern
  • occurs at rest
  • last > 10 minutes
100
Q

Myocardial Infarction

A
  • sudden and extended obstruction of the myocardial blood supply
  • subendocardial infarction (NSTEMI)
  • transmural infarction
101
Q

Myocardial Infarction Diagnosis

A
  • clinical assessment
  • complete CV and neuro exam
  • EKG changes
  • cardiac enzymes (troponins most specific, see in 2-4 hrs, speaks in 24hrs, remains elevated for 7-10 days)
  • CK-MB (see in 2-4 hr, peaks in 24 hrs)
  • LDH (will show tissue damage)
  • hyperglycemia 72 hrs post MI
102
Q

Acute Myocardial Infarction Treatment

A

M - morphine
O - oxygen
N - nitrates
A - aspirin
**Caveat: if patient is having inferior MI, perform right sided EKG and do NOT give morphine

103
Q

Post Myocardial Infarction Treatment

A
  • beta blockers are recommended (do not give in acute heart failure)
  • ACE inhibitors (ARBs if cannot tolerate ACEs)
  • antiplatelet therapy (aspirin or plavix)
  • DM management
  • lipid management
  • nitroglycerin and calcium channel blockers can be used to treat ischemic symptoms without significant renal dysfunction
104
Q

Cardiovascular Syncope Causes

A

associated with decreased cardiac output or obstruction

105
Q

Electrical Causes of Syncope

A
  • arrhythmias
  • heart block
  • Brugada syndrome
106
Q

Mechanical Causes of Syncope

A
  • idiopathic subaortic stenosis
  • hypertrophic obstructive cardiomyopathy
  • valvular diseases
  • myxoma
  • MI
  • pulmonary embolus
107
Q

Syncope Diagnostic Studies

A
  • goal is to identify life-threatening conditions or those associated with significant risk of injury
  • detailed history and physical exam
  • EKG
  • CMP: glucose, calcium, sodium
  • Holter monitor
  • measure BP in both arms (a difference of 20 mm Hg or more is considered abnormal)
108
Q

When to hospitalize syncope patients…

A
  • known or serious CV disease
  • significant EKG changes
  • acute symptoms of chest pain or symptoms of PE
  • disabling episodes of recurrent syncope
  • syncope involving injury, rapid pulses or exertional syncope